Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus

被引：1
|
作者：
Kaplan, Alyson [1 ]
DeHaan, Elliott [2 ]
Maltz, Charles [1 ]
机构：
[1] New York Presbyterian, Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Sch Med, New York, NY 10065 USA
[2] New York Presbyterian, Dept Med, Div Infect Dis, Weill Cornell Sch Med, New York, NY USA
来源：
ACG CASE REPORTS JOURNAL | 2021年 / 8卷 / 05期
关键词：
MONOCLONAL-ANTIBODY; HIV-1;
D O I：
10.14309/crj.0000000000000594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Despite the decreasing morbidity associated with the human immunodeficiency virus (HIV), a large percentage of persons with HIV have at least 1 drug resistance mutation. Ibalizumab, a recently approved drug, targets multidrug-resistant HIV. We present a case of reactivation of hepatitis B after initiation of ibalizumab therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Management of multidrug-resistant tuberculosis in human immunodeficiency virus patients
    Jamil, K. F.
    1ST INT CONF ON TROP MED & INFECT DIS FAC OF MED UNIV SUMATERA UTARA IN CONJUNCTION WITH THE 23RD NATL CONGRESS OF THE INDONESIAN SOC OF TROP & INFECT DIS CONSULTANT AND THE 18TH ANNUAL MEETING OF INTERNAL MED DEPT FAC OF MED UNIV SUMATERA UTARA, 2018, 125
  • [2] Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty
    Sheikh, Virginia
    Murray, Jeffrey S.
    Sherwat, Adam
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (07): : 605 - 607
  • [3] Multidrug-Resistant Chronic Hepatitis B - Impact on Therapy Outcome
    Vilas-Boas, Filipe
    Cardoso, Helder
    Coelho, Rosa
    Rodrigues, Susana
    Lopes, Susana
    Sarmento, Jose Alexandre
    Pereira, Pedro
    Horta e Vale, Ana
    Arajo, Fernando
    Macedo, Guilherme
    GASTROENTEROLOGY, 2014, 146 (05) : S925 - S925
  • [4] Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus
    Lawrence, J
    Mayers, DL
    Hullsiek, KH
    Collins, G
    Abrams, DI
    Reisler, RB
    Crane, LR
    Schmetter, BS
    Dionne, TJ
    Saldanha, JM
    Jones, MC
    Baxter, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09): : 837 - 846
  • [5] Ibalizumab-uiyk (Trogarzo) for Multidrug-Resistant HIV
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1545): : 68 - 69
  • [6] Multidrug-Resistant Hepatitis B Virus Strain in a Chronic Turkish Patient
    Sayan, Murat
    Hulagu, Sadettin
    Karatayli, Sinem Ceren
    HEPATITIS MONTHLY, 2010, 10 (02) : 141 - 146
  • [7] Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
    Iversen, AKN
    Shafer, RW
    Wehrly, K
    Winters, MA
    Mullins, JI
    Chesebro, B
    Merigan, TC
    JOURNAL OF VIROLOGY, 1996, 70 (02) : 1086 - 1090
  • [8] Transmission of multidrug-resistant human immunodeficiency virus - The wake-up call
    Cohen, OJ
    Fauci, AS
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05): : 341 - 343
  • [9] Novel Use of Fostemsavir for 2 Multidrug-Resistant Persons With Human Immunodeficiency Virus
    Pecora Fulco, Patricia
    Nixon, Daniel
    Gomes, Denese C.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (04) : 501 - 502
  • [10] Outcome of multidrug-resistant tuberculosis in human immunodeficiency virus-infected patients
    Franzetti, F
    Gori, A
    Iemoli, E
    Meraviglia, P
    Mainini, F
    Quirino, T
    degli Esposti, A
    degl'Innocenti, M
    Grassini, A
    Nardi, G
    Cargnel, A
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 553 - 560
12345